Тендеры России
Поиск
A Pembrolizumab (Genetical Recombination) IV Infusion 100 mg set of 1 vial: approx. 740 sets B Daratumumab (Genetical Recombination) Vorhyaluronidase Alfa (Genetical Recombination) Combination SC injection set of 1 vial: approx. 350 sets C Ravuliz... (Япония - Тендер #65912885) | ||
| ||
| Для перевода текста тендера на нужный язык воспользуйтесь приложением: | ||
Страна: Япония (другие тендеры и закупки Япония) Организатор тендера: Procurement Notices of Japanese Local Government Номер конкурса: 65912885 Дата публикации: 01-08-2025 Источник тендера: Procurement Notices of Japanese Local Government |
||
| Publishing date | Jul 31, 2025 |
|---|---|
| Procurement entity | Sapporo City(Hokkaido) |
| Classification | 0004 Medical & Pharmaceutical Products |
| Summary of notice |
Summary (1) Nature and the quantity of the products to be procured A Pembrolizumab (Genetical Recombination) IV Infusion 100 mg set of 1 vial: approx. 740 sets B Daratumumab (Genetical Recombination) Vorhyaluronidase Alfa (Genetical Recombination) Combination SC injection set of 1 vial: approx. 350 sets C Ravulizumab (Genetical Recombination) IV Infusion 300 mg/3mL set of 1 vial: approx. 189 sets D Epcoritamab (Genetical Recombination) SC injection 48 mg set of 1 vial: approx. 55 sets E Aflibercept (Genetical Recombination) 8 mg IVT injection 114.3 mg/mL set of 1 kit: approx. 458 sets F Atezolizumab (Genetical Recombination) IV Infusion 1200 mg/20mL set of 1 vial: approx. 137 sets G Aflibercept (Genetical Recombination) 2 mg IVT injection 40 mg/mL set of 1 kit: approx. 538 sets H Nivolumab (Genetical Recombination) kit for IV Infusion 240 mg set of 1 vial: approx. 213 sets I Lenalidomide Hydrate Capsules 5 mg set of 40 capsules: approx. 192 sets J Durvalumab (Genetical Recombination) IV Infusion 500 mg/10mL set of 1 vial: approx. 214 sets K Elranatamab (Genetical Recombination) SC injection 76 mg/1.9mL set of 1 vial: approx. 58 sets L Brentuximab Vedotin (Genetical Recombination) IV infusion 50 mg set of 1 vial: approx. 111 sets M Risankizumab (Genetical Recombination) SC 150 mg pen 1 mL set of 1 vial: approx. 91 sets N Enfortumab Vedotin (Genetical Recombination) IV infusion 30 mg set of 1 viral: approx. 452 sets (2) Time limit for tender: 17:00 on September 5 (Fri.), 2025 (3) Contact point for the notice: Management & Planning Section, Management Department, Management Office, Hospital Bureau, Sapporo Municipal Government, Kita 11-jo Nishi 13- chome, Chuo-ku, Sapporo 060-8604, Japan. TEL 011-726-2211 |